The demand for advanced therapies has exploded. And so has the need to generate billions of viable cells necessary to take your discoveries from hopeful promise in the lab to safe, effective patient treatments for the world’s most challenging diseases. Corning partners with you from start-up to scale-up using our innovative, closed-system, adherent and suspension-based solutions to support the transition from cultures at the bench to large scale cell production.
Advanced Cell And Gene Therapy- Partner With Corning From Start-Up To Scale-Up
Source: Corning Life Sciences
A Bold New Era for Advanced Therapies
Our expert team draws on decades of experience in cell culture and bioprocess to help you select and optimize the best technology platform to meet your production goals. We partner with you to adapt techniques, customize your process and streamline workflow. Corning supports your advanced therapies program with:
- Scale-up and Scale-out workflow design
- Optimized surface and media selection based on application
- Assistance with manufacturing processes and protocol development
- Design and implementation support for closed-system manufacturing platforms
Our broad range of cell culture systems and platform, as well as advanced surfaces are well-suited to support academic, biotech, and pharmaceutical laboratories, as well as CMOs and cell banks.
Quality That Supports The Path To Clinical Trials
Corning products for cell and gene therapy application that are classified as medical devices in the United States of America are manufactured following FDA 21 CFR 820, also known as cGMP. Our robust quality management system ensures reliable products to support your next breakthrough.
Consistency
Corning helps you maintain consistent quality as you scale-up from Phase I clinical trials to large-scale commercial manufacturing. We are nimble enough to offer you customized solutions to address your specific needs.
Proven Platform
We have a century of cell culture product development experience and a long history in bioprocess. Our expertise and proven technologies, such as Corning® HYPERStack® have made Corning a lab mainstay.
Continuous Innovation
We continue to evolve our portfolio to help you push your science further. Recent innovations, such as the Corning® Ascent® Fixed Bed Bioreactor (FBR) System, help support and streamline cell therapy applications, vaccine production, and large-volume adherent cell culture scale-up and cell banking.
Corning Life Sciences
This website uses cookies to ensure you get the best experience on our website. Learn more